Abstract

The Syrian conflict has caused enormous displacement of a population with a high non-communicable disease (NCD) burden into surrounding countries, overwhelming health systems’ NCD care capacity. Médecins sans Frontières (MSF) developed a primary-level NCD programme, serving Syrian refugees and the host population in Irbid, Jordan, to assist the response. Cost data, which are currently lacking, may support programme adaptation and system scale up of such NCD services. This descriptive costing study from the provider perspective explored financial costs of the MSF NCD programme. We estimated annual total, per patient and per consultation costs for 2015–17 using a combined ingredients-based and step-down allocation approach. Data were collected via programme budgets, facility records, direct observation and informal interviews. Scenario analyses explored the impact of varying procurement processes, consultation frequency and task sharing. Total annual programme cost ranged from 4 to 6 million International Dollars (INT$), increasing annually from INT$4 206 481 (2015) to INT$6 739 438 (2017), with costs driven mainly by human resources and drugs. Per patient per year cost increased 23% from INT$1424 (2015) to 1751 (2016), and by 9% to 1904 (2017), while cost per consultation increased from INT$209 to 253 (2015–17). Annual cost increases reflected growing patient load and increasing service complexity throughout 2015–17. A scenario importing all medications cut total costs by 31%, while negotiating importation of high-cost items offered 13% savings. Leveraging pooled procurement for local purchasing could save 20%. Staff costs were more sensitive to reducing clinical review frequency than to task sharing review to nurses. Over 1000 extra patients could be enrolled without additional staffing cost if care delivery was restructured. Total costs significantly exceeded costs reported for NCD care in low-income humanitarian contexts. Efficiencies gained by revising procurement and/or restructuring consultation models could confer cost savings or facilitate cohort expansion. Cost effectiveness studies of adapted models are recommended.

Highlights

  • Non-communicable diseases (NCDs) have been responsible for the majority of deaths worldwide for more than three decades, causing 71% of the 56.9 million global deaths in 2016 (World Health Organization, 2018)

  • Using the Medecins sans Frontieres (MSF) Green list, specific items on the Irbid project medication list were substituted with clinically equivalent alternatives, and, in cases where multiple formulations were used in Irbid but only a single formulation was available from Amsterdam Procurement Unit (APU), we proposed purchasing the equivalent number of milligrams consumed in 2017 from APU (Supplementary File S3)

  • Most cost categories accounted for a similar proportion of annual expenditure across years, drug costs increased by 9% from 2015 to 2016

Read more

Summary

Introduction

Non-communicable diseases (NCDs) have been responsible for the majority of deaths worldwide for more than three decades, causing 71% (or 40.5 million) of the 56.9 million global deaths in 2016 (World Health Organization, 2018). Following the prolonged conflict in Syria, in its ninth year, almost 6.6 million refugees have fled, mainly into neighbouring countries; 670 000 refugees registered with the United Nations High Commissioner for Refugees (UNHCR) fled to Jordan. Jordan’s second largest city, hosts over 165 000 refugees, the largest concentration after Amman (UNHCR, 2018a). Most live in urban settings, amongst the host community (UNHCR, 2018a). Previous studies confirmed the high burden of NCDs amongst Syrian refugees in Jordan (Doocy et al, 2015, 2016) and Jordan’s public health system has been challenged to respond to this additional burden. The humanitarian health system has supported the public health system response, adapting traditional camp-based care provision to serve urban-dwelling refugees (UNHCR et al, 2014; UNHCR, 2018b; Akik et al, 2019)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call